CytoReason
✓ Verified
Healthcare AI
computational disease modeling / drug discovery
Series B1
CytoReason is a private AI healthcare company that develops computational disease models to help biopharma companies make drug-development decisions across target selection, indication prioritization, combination strategy, and patient stratification. Its platform combines molecular and clinical data to simulate disease biology at the tissue and cell level, and it is used by multiple top global pharma companies.
Company Details
- Website
- cytoreason.com
- Headquarters
- Tel Aviv, Israel
- Founded
- 2016
- Funding
- $180M
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring